Published in Heart on April 18, 2006
Cardiac remodeling in obesity. Physiol Rev (2008) 2.95
Resistin, adiponectin, and risk of heart failure the Framingham offspring study. J Am Coll Cardiol (2008) 2.18
Effects of tempol and redox-cycling nitroxides in models of oxidative stress. Pharmacol Ther (2010) 1.66
Adiponectin protects against the development of systolic dysfunction following myocardial infarction. J Mol Cell Cardiol (2007) 1.55
Adiponectin modulates oxidative stress-induced autophagy in cardiomyocytes. PLoS One (2013) 1.01
Dietary fat and heart failure: moving from lipotoxicity to lipoprotection. Circ Res (2012) 1.00
The usefulness of circulating adipokine levels for the assessment of obesity-related health problems. Int J Med Sci (2008) 0.99
Effects of adiponectin deficiency on structural and metabolic remodeling in mice subjected to pressure overload. Am J Physiol Heart Circ Physiol (2010) 0.94
Dynamics in insulin resistance and plasma levels of adipokines in patients with acute decompensated and chronic stable heart failure. J Card Fail (2011) 0.93
Direct effects of adipokines on the heart: focus on adiponectin. Heart Fail Rev (2013) 0.92
Relation of plasma adiponectin levels and aortic stiffness after acute ST-segment elevation myocardial infarction. Eur Heart J Acute Cardiovasc Care (2013) 0.92
ω-3 Polyunsaturated fatty acids prevent pressure overload-induced ventricular dilation and decrease in mitochondrial enzymes despite no change in adiponectin. Lipids Health Dis (2010) 0.91
Adiponectin, diabetes and ischemic heart failure: a challenging relationship. Cardiovasc Diabetol (2012) 0.91
Plasma adiponectin concentration and its association with metabolic syndrome in patients with heart failure. Yonsei Med J (2012) 0.88
G-protein-coupled receptor kinase 2-mediated desensitization of adiponectin receptor 1 in failing heart. Circulation (2015) 0.88
New and emerging biomarkers in left ventricular systolic dysfunction--insight into dilated cardiomyopathy. J Cardiovasc Transl Res (2013) 0.87
Determinants of adiponectin levels in patients with chronic systolic heart failure. Am J Cardiol (2010) 0.87
Adiponectin through its biphasic serum level is a useful biomarker during transition from diastolic dysfunction to systolic dysfunction - an experimental study. Lipids Health Dis (2012) 0.84
What can adiponectin say about left ventricular function? Heart (2009) 0.84
Mutual Regulation of Epicardial Adipose Tissue and Myocardial Redox State by PPAR-γ/Adiponectin Signalling. Circ Res (2016) 0.84
Association between adiponectin and heart failure risk in the physicians' health study. Obesity (Silver Spring) (2013) 0.83
Gender differences in adiponectin modulation of cardiac remodeling in mice deficient in endothelial nitric oxide synthase. J Cell Biochem (2012) 0.83
Hypoadiponectinemia in patients with paroxysmal atrial fibrillation. Korean Circ J (2012) 0.80
Adiponectin: key role and potential target to reverse energy wasting in chronic heart failure. Heart Fail Rev (2013) 0.80
Serum Angiopoietin-Like Protein 2 Concentrations Are Independently Associated with Heart Failure. PLoS One (2015) 0.79
Body mass index in chronic heart failure: association with biomarkers of neurohormonal activation, inflammation and endothelial dysfunction. BMC Cardiovasc Disord (2013) 0.79
Relationship between serum cystatin C and serum adiponectin level in type 2 diabetic patients. Clin Exp Nephrol (2011) 0.79
Inhibition of G-protein-coupled Receptor Kinase 2 Prevents the Dysfunctional Cardiac Substrate Metabolism in Fatty Acid Synthase Transgenic Mice. J Biol Chem (2015) 0.78
Adiponectin resistance in skeletal muscle: pathophysiological implications in chronic heart failure. J Cachexia Sarcopenia Muscle (2015) 0.78
Serum adiponectin and cardiometabolic risk in patients with acute coronary syndromes. Arq Bras Cardiol (2013) 0.77
Effect of physiological determinants and cardiac disease on plasma adiponectin concentrations in dogs. J Vet Intern Med (2014) 0.77
A randomized, controlled trial of the effects of rosiglitazone on adipokines, and inflammatory and fibrinolytic markers in diabetic patients: study design and protocol. Can J Cardiol (2008) 0.76
Inside out: Bone marrow adipose tissue as a source of circulating adiponectin. Adipocyte (2016) 0.76
Dysregulation of Autonomic Nervous System in Chagas' Heart Disease Is Associated with Altered Adipocytokines Levels. PLoS One (2015) 0.75
Serum Concentrations of Leptin and Adiponectin in Dogs with Myxomatous Mitral Valve Disease. J Vet Intern Med (2016) 0.75
Circulating Omentin-1 Levels Are Decreased in Dilated Cardiomyopathy Patients with Overt Heart Failure. Dis Markers (2016) 0.75
Salivary and serum adiponectin and C-reactive protein levels in acute myocardial infarction related to body mass index and oral health. J Periodontal Res (2016) 0.75
Correlation between Plasma Adiponectin Levels and the Presence and Severity of Coronary Artery Disease. J Tehran Heart Cent (2013) 0.75
Relationship of Plasma Adiponectin and Waist-hip Ratio with Coronary Artery Disease. Med Arch (2016) 0.75
Nitric oxide bioavailability and adiponectin production in chronic systolic heart failure: relation to severity of cardiac dysfunction. Transl Res (2013) 0.75
Nitric oxide/cyclic GMP pathway mediates the endothelin-1-upregulation of adiponectin expression in rat cardiomyocytes. Biomed Rep (2017) 0.75
The evolving role of adiponectin as an additive biomarker in HFrEF. Heart Fail Rev (2016) 0.75
Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun (1999) 14.25
Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol (2000) 9.85
Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab (2001) 9.53
Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation (2000) 6.96
Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia (2003) 5.91
Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med (1990) 5.65
Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol (2003) 4.86
Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation (2002) 3.81
Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation (2003) 3.73
Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet (2002) 3.68
Hormones and hemodynamics in heart failure. N Engl J Med (1999) 3.50
Association between adiponectin and mediators of inflammation in obese women. Diabetes (2003) 2.05
Adiponectin and its role in the obesity-induced insulin resistance and related complications. Physiol Res (2004) 1.52
Heart failure as an inflammatory condition: potential role for androgens as immune modulators. Eur J Heart Fail (2002) 1.14
Decreased plasma adiponectin concentrations in women with low-grade C-reactive protein elevation. Eur J Endocrinol (2003) 1.07
Heart Failure Society of America (HFSA) practice guidelines. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction--pharmacological approaches. J Card Fail (1999) 1.00
Haemodynamic, neuroendocrine and metabolic correlates of circulating cytokine concentrations in congestive heart failure. Eur Heart J (1997) 0.89
Physiology and anatomy of synaptic connections between thick tufted pyramidal neurones in the developing rat neocortex. J Physiol (1997) 5.94
eggNOG v2.0: extending the evolutionary genealogy of genes with enhanced non-supervised orthologous groups, species and functional annotations. Nucleic Acids Res (2009) 4.55
The Worm Community System, release 2.0 (WCSr2). Methods Cell Biol (1995) 4.18
The Memorial Delirium Assessment Scale. J Pain Symptom Manage (1997) 3.55
Are beta-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review. JAMA (1998) 3.37
Propagation of action potentials in dendrites depends on dendritic morphology. J Neurophysiol (2001) 3.05
Canagliflozin, a novel inhibitor of sodium glucose co-transporter 2, dose dependently reduces calculated renal threshold for glucose excretion and increases urinary glucose excretion in healthy subjects. Diabetes Obes Metab (2011) 3.00
The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol (2000) 2.52
The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. J Am Coll Cardiol (2001) 2.45
Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection. Antimicrob Agents Chemother (2006) 2.31
Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm: the effect of no treatment and high-dose amiodarone. A randomized, placebo-controlled study. Eur Heart J (1999) 2.21
Submillisecond AMPA receptor-mediated signaling at a principal neuron-interneuron synapse. Neuron (1997) 2.14
Macrophage specificity of three anti-CD68 monoclonal antibodies (KP1, EBM11, and PGM1) widely used for immunohistochemistry and flow cytometry. Ann Rheum Dis (2004) 2.09
Is trauma in Switzerland any different? epidemiology and patterns of injury in major trauma - a 5-year review from a Swiss trauma centre. Swiss Med Wkly (2014) 2.07
A versatile plasmid vector system for the regulated expression of genes in Escherichia coli. Biotechniques (1994) 2.02
The FIS protein binds and bends the origin of chromosomal DNA replication, oriC, of Escherichia coli. Nucleic Acids Res (1991) 2.02
Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK. Ann Oncol (2008) 1.99
Characteristics of respondents and non-respondents to a mailed questionnaire. Am J Public Health (1980) 1.94
Serum IgE levels in healthy children quantified by a sandwich technique (PRIST). Clin Allergy (1976) 1.83
Diuretic induced hyponatraemia in elderly hypertensive women. J Hum Hypertens (2002) 1.81
The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies. N Engl J Med (1989) 1.75
Serologic evidence of human monocytic and granulocytic ehrlichiosis in Israel. Emerg Infect Dis (2000) 1.68
Adjuvant treatment of colorectal cancer (current expert opinion derived from the Third International Conference: Perspectives in Colorectal Cancer, Dublin, 2001). Eur J Cancer (2002) 1.66
Circadian variation of symptomatic paroxysmal atrial fibrillation. Data from almost 10 000 episodes. Eur Heart J (1999) 1.63
Isolation and characterization of rheumatoid arthritis synovial fibroblasts from primary culture--primary culture cells markedly differ from fourth-passage cells. Arthritis Res (2000) 1.62
Nilotinib in the treatment of advanced gastrointestinal stromal tumours resistant to both imatinib and sunitinib. Eur J Cancer (2009) 1.62
Does diuretic therapy increase the risk of renal cell carcinoma? Am J Cardiol (1999) 1.60
Effects of losartan and candesartan monotherapy and losartan/hydrochlorothiazide combination therapy in patients with mild to moderate hypertension. Losartan Trial Investigators. Clin Ther (2000) 1.59
Should thrombolytic therapy be administered in the mobile intensive care unit in patients with evolving myocardial infarction? A pilot study. J Am Coll Cardiol (1990) 1.58
RAST, skin and nasal tests and the history in grass pollen allergy. Clin Allergy (1975) 1.56
[Development and implementation of integrated health care in pain medicine : the nationwide German headache treatment network]. Schmerz (2009) 1.56
Analysis of coronary ultrasound thrombolysis endpoints in acute myocardial infarction (ACUTE trial). Results of the feasibility phase. Circulation (1997) 1.47
Recognition models of alphanumeric characters. Percept Psychophys (1981) 1.45
The management of pancreatic cancer. Current expert opinion and recommendations derived from the 8th World Congress on Gastrointestinal Cancer, Barcelona, 2006. Ann Oncol (2007) 1.44
Mechanical milling assisted by electrical discharge. Nature (2002) 1.43
Value of PCR for evaluating occurrence of parasitemia in immunocompromised patients with cerebral and extracerebral toxoplasmosis. J Clin Microbiol (1994) 1.41
Lassa fever encephalopathy: Lassa virus in cerebrospinal fluid but not in serum. J Infect Dis (2001) 1.40
High-dose intravenous magnesium attenuates complement consumption after acute myocardial infarction treated by streptokinase. Eur Heart J (1996) 1.40
Lymphocytes of healthy subjects and schizophrenic patients possess no high-affinity binding sites for spiroperidol. Pharmacopsychiatry (1990) 1.40
Aminophylline for bradyasystolic cardiac arrest refractory to atropine and epinephrine. Ann Intern Med (1993) 1.39
The effects of a combined low-sodium, high-potassium, high-calcium diet on blood pressure in patients with mild hypertension. J Hum Hypertens (1997) 1.39
Radial capillary array electrophoresis microplate and scanner for high-performance nucleic acid analysis. Anal Chem (1999) 1.38
Estimating the time course of the excitatory synaptic conductance in neocortical pyramidal cells using a novel voltage jump method. J Neurosci (1997) 1.38
Treatment of hypertension by enalapril and hydrochlorothiazide separately and together: a multicenter study. Isr J Med Sci (1990) 1.38
Elevated plasma atrial natriuretic peptide levels after occlusion of the thoracic aorta. Chest (1999) 1.37
A comprehensive set of DnaA-box mutations in the replication origin, oriC, of Escherichia coli. Mol Microbiol (1996) 1.32
Letter: Cardiotoxicity of 5-fluorouracil (NSC-19893) Cancer Chemother Rep (1976) 1.31
Diagnosis of penicillin allergy by means of Phadebas RAST penicilloyl G and V and skin tests. Clin Allergy (1981) 1.27
Plasma levels of catechols and metanephrines in neurogenic orthostatic hypotension. Neurology (2003) 1.26
Dendritic and somatic glutamate receptor channels in rat cerebellar Purkinje cells. J Physiol (1997) 1.24
Competitive calcium binding: implications for dendritic calcium signaling. J Comput Neurosci (1998) 1.23
Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02). Ann Oncol (2009) 1.20
The plasma concentration and LDL-C relationship in patients receiving ezetimibe. J Clin Pharmacol (2001) 1.13
Genetic parameters for clinical mastitis, somatic cell score, and production in the first three lactations of Swedish holstein cows. J Dairy Sci (2004) 1.13
Positron emission tomographic imaging of cardiac sympathetic innervation using 6-[18F]fluorodopamine: initial findings in humans. J Am Coll Cardiol (1993) 1.13
Skin tags: a cutaneous marker for diabetes mellitus. Acta Derm Venereol (1987) 1.12
Nonlinear anisotropic diffusion filtering of three-dimensional image data from two-photon microscopy. J Biomed Opt (2004) 1.11
Prevalence and determinants of erectile dysfunction in hemodialysis patients. Kidney Int (2001) 1.10
Incidence of early tolerance to hemodynamic effects of continuous infusion of nitroglycerin in patients with coronary artery disease and heart failure. Circulation (1987) 1.10
Pause-dependent torsade de pointes following acute myocardial infarction: a variant of the acquired long QT syndrome. J Am Coll Cardiol (2001) 1.10
The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010. Ann Oncol (2011) 1.10
Academic geriatrics for the year 2000. An Institute of Medicine report. N Engl J Med (1987) 1.09
Intravascular ultrasound evaluation of the effect of rotational atherectomy in obstructive atherosclerotic coronary artery disease. Circulation (1992) 1.09
The significance of hypertensive response to exercise as a predictor of hypertension and cardiovascular disease. J Hum Hypertens (2001) 1.09
Is spinal cord isolation a good model of muscle disuse? Muscle Nerve (2007) 1.07
Rotavirus encephalopathy: evidence of central nervous system involvement during rotavirus infection. Pediatr Infect Dis J (1992) 1.06
Wnt-5a and Wnt-7a are expressed in the developing chick limb bud in a manner suggesting roles in pattern formation along the proximodistal and dorsoventral axes. Mech Dev (1993) 1.06
Diuretics, beta-blockers, and gin and tonic. Eur Heart J (1999) 1.06
IgE screening in 1701 newborn infants and the development of atopic disease during infancy. Arch Dis Child (1982) 1.05
Interrelationship of mid-diastolic mitral valve motion, pulmonary venous flow, and transmitral flow. Circulation (1986) 1.05
SOS induction in Escherichia coli by infection with mutant filamentous phage that are defective in initiation of complementary-strand DNA synthesis. J Bacteriol (1992) 1.04
Acute mastoiditis--the antibiotic era: a multicenter study. Int J Pediatr Otorhinolaryngol (2001) 1.04
Structural and physicochemical requirements of endotoxins for the activation of arachidonic acid metabolism in mouse peritoneal macrophages in vitro. Eur J Biochem (1989) 1.04
Pulmonary venous flow pattern--its relationship to cardiac dynamics. A pulsed Doppler echocardiographic study. Circulation (1985) 1.04
On the association between hypercholesterolemia, cardiovascular disease and severe periodontal disease. J Clin Periodontol (2001) 1.04
Who responds to sugar pills? Mayo Clin Proc (1976) 1.03
The in-vitro anti-rickettsial activity of macrolides. J Antimicrob Chemother (1996) 1.03
Isolation of Nocardia paucivorans from the cerebrospinal fluid of a patient with relapse of cerebral nocardiosis. J Clin Microbiol (2002) 1.03
A label-free, impedance-based real time assay to identify drug-induced toxicities and differentiate cytostatic from cytotoxic effects. Toxicol In Vitro (2012) 1.03
A comparison of various methods for the determination of VO2max. Eur J Appl Physiol Occup Physiol (1980) 1.03
Calculation of mean arterial pressure during exercise as a function of heart rate. Appl Human Sci (1995) 1.03
Oral yohimbine increases blood pressure and sympathetic nervous outflow in hypertensive patients. J Cardiovasc Pharmacol (1993) 1.02
Diagnostic value of liver biopsy in alcoholic liver disease. J Clin Gastroenterol (1988) 1.02
Effects of salts and ionophores on proline transport in a moderately halopholic halotolerant bacterium. Biochim Biophys Acta (1980) 1.02
Effects of early treatment with immunoglobulin on critical illness polyneuropathy following multiple organ failure and gram-negative sepsis. Intensive Care Med (1997) 1.01
The complex for replication initiation of Escherichia coli. Chromosoma (1992) 1.01
Plasma protein-binding parameters of prednisolone in immune disease patients receiving long-term prednisone therapy. J Lab Clin Med (1981) 1.01
Effect of hyperglycemia and hyperlipidemia on atherosclerosis in LDL receptor-deficient mice: establishment of a combined model and association with heat shock protein 65 immunity. Diabetes (2000) 1.01
New strategies and designs in pancreatic cancer research: consensus guidelines report from a European expert panel. Ann Oncol (2011) 1.00
Parameters of red blood cell aggregation as correlates of the inflammatory state. Am J Physiol Heart Circ Physiol (2001) 1.00
Optimisation of irinotecan dose in the treatment of patients with metastatic colorectal cancer after 5-FU failure: results from a multinational, randomised phase II study. Br J Cancer (2005) 1.00
Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany. Arch Dermatol (1995) 1.00
Hemodynamic and humoral effects of the angiotensin II antagonist losartan in essential hypertension. Am J Hypertens (1994) 1.00